CARLSMED, INC. financial data

Symbol
CARL on Nasdaq
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity -259% % -755%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,731,992 shares
Common Stock, Shares, Outstanding 26,604,505 shares 543%
Entity Public Float $0 USD
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 21,081,330 shares 416%
Weighted Average Number of Shares Outstanding, Diluted 21,081,330 shares 416%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $3,147,000 USD 76%
Research and Development Expense $4,445,000 USD 10%
Selling and Marketing Expense $9,610,000 USD 45%
General and Administrative Expense $4,907,000 USD 156%
Operating Income (Loss) $9,035,000 USD -16%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $29,634,000 USD -22%
Earnings Per Share, Basic -0.4 USD/shares 81%
Earnings Per Share, Diluted -0.4 USD/shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $85,793,000 USD 114%
Accounts Receivable, after Allowance for Credit Loss, Current $11,362,000 USD 68%
Inventory, Net $1,845,000 USD 85%
Assets, Current $126,673,000 USD 157%
Property, Plant and Equipment, Net $1,487,000 USD 472%
Operating Lease, Right-of-Use Asset $1,826,000 USD 11%
Other Assets, Noncurrent $134,000 USD -76%
Assets $130,120,000 USD 151%
Accounts Payable, Current $4,481,000 USD 86%
Accrued Liabilities, Current $3,287,000 USD 22%
Liabilities, Current $14,280,000 USD 62%
Operating Lease, Liability, Noncurrent $1,316,000 USD -0.08%
Other Liabilities, Noncurrent $309,000 USD 39%
Liabilities $31,251,000 USD 19%
Retained Earnings (Accumulated Deficit) $100,805,000 USD -42%
Stockholders' Equity Attributable to Parent $98,869,000 USD
Liabilities and Equity $130,120,000 USD 151%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 600,000,000 shares 2648%
Common Stock, Shares, Issued 26,664,243 shares 530%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance $26,369,000 USD 44%
Deferred Tax Assets, Gross $26,839,000 USD 43%
Operating Lease, Liability $2,068,000 USD
Depreciation $100,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $8,526,000 USD -9.1%
Lessee, Operating Lease, Liability, to be Paid $2,293,000 USD
Property, Plant and Equipment, Gross $2,013,000 USD 205%
Operating Lease, Liability, Current $752,000 USD 67%
Lessee, Operating Lease, Liability, to be Paid, Year Two $926,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $895,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.0863 pure -5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $225,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $472,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $17,902,000 USD 64%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Unrecognized Tax Benefits $600,000 USD 50%
Additional Paid in Capital $199,674,000 USD 36808%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $470,000 USD 16%
Share-based Payment Arrangement, Expense $704,000 USD 967%
Interest Expense $380,000 USD -5.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%